antibody-drug conjugate

Advertisement

cGxPJobs Banner

Tagworks Advances TGW101 in Phase 1 Trial for Solid Tumors

NIJMEGEN, Netherlands and BOSTON, September 9, 2025 — Tagworks Pharmaceuticals has initiated the third dose level in its ongoing...

By cGxPwire Editor
September 10, 2025

Read More

Advertisement

cGxPJobs

Directory